Global Brain Disorders Research

Status: Accepting applications

Announcement(s)

Global Brain and Nervous System Disorders Research across the Lifespan (R21 Clinical Trials Optional) (PAR-18-836)
Global Brain and Nervous System Disorders Research across the Lifespan (R01 Clinical Trials Optional) (PAR-18-835)

Deadlines

Letter of intent due dates (optional, non-binding): 30 days prior to the application due date
Upcoming application due date: November 6, 2020

Notice to Extend the Expiration Date and Change Receipt Dates for Global Brain and Nervous System Disorders Research Across the Lifespan PAR-18-836 (R21 Clinical Trial Optional) (NOT-TW-18-008), released October 30, 2018; and PAR-18-835 (R01 Clinical Trials Optional) (NOT-TW-18-007), released November 1, 2018

Eligibility

Scientists at U.S. or upper-middle-income country institutions must partner with scientists at low-income, lower-middle-income or upper-middle-income country institutions. (Income categories are defined by The World Bank Country and Lending Groups.)
Applicants are encouraged to consult with participating NIH Institutes or Offices (see list of partners below) while developing their applications.
The proposed research must be relevant to the interests stated in the funding opportunity announcement of one of the participating NIH Institutes or Offices.
Applicants who need time and funding to develop research collaborations and capacity, and to conduct pilot studies, are encouraged to apply first to the R21 (PAR-14-331).
Applicants to the R01 must build on established research, research collaborations and research capacity building activities at LMIC site(s).
Applications on research topics related to chronic, noncommunicable diseases should apply to Fogarty's Global Noncommunicable Diseases and Injury Research.

Program Overview

The Global Brain and Nervous System Disorders Research across the Lifespan program supports collaborative research and capacity building projects relevant to LMICs on brain and nervous system disorders throughout life. Grant recipients develop innovative, collaborative research programs that contribute to the long-term goal of building sustainable research capacity in nervous system function and nervous system impairment.

Exploratory and developmental research grants through the R21 announcement help researchers develop collaborations, build research capacity and conduct pilot studies. Research grants through the R01 announcement support well-developed research collaborations and research capacity building for research networks within institutions, countries or regions.

Email Updates - Subscribe to the Global Brain and Nervous System Disorders LISTSERV to receive updates on this program and related issues. Send an email to listserv@list.nih.gov and type "subscribe brain-FIC-L" in the body of the email.

Grant Awards

Current Global Brain Disorders full awards and planning grants for fiscal years 2013 through 2018
Archive of Global Brain Disorders full awards
Archive of Global Brain Disorders planning grant awards

Frequently Asked Questions

Access answers to frequently asked questions (FAQs) about the Global Brain Disorders RFAs.

Inquiries

Programmatic Issues

Dr. Kathleen Michels
Program Director
Division of International Research and Training
Fogarty International Center
Building 31, Room B2C39
31 Center Drive MSC 2220
Bethesda, MD 20892-2220
Telephone: (301) 496-1653
FAX: (301) 402-0779
Email: brainfic@nih.gov

Grants Management

Mollie Shea
Grants Management Specialist
Fogarty International Center
National Institutes of Health
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Mollie.Shea@nih.gov

Partners

The following NIH Institutes and Offices are participating in this program with Fogarty: